{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:55:22Z","timestamp":1790916922315,"version":"4.1.0"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>This study investigated the associations of multiregional macular and peripapillary OCTA metrics and systemic hematologic biomarkers with 12-month diabetic retinopathy progression and evaluated whether their combination improved prognostic discrimination.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This single-center longitudinal cohort study included 55 adults with type 2 diabetes and established DR, contributing 108 eyes. Baseline macular and peripapillary vessel density parameters were obtained by OCTA, and peripheral blood laboratory markers were measured. DR progression was defined as worsening by at least two steps on the Diabetic Retinopathy Severity Scale (DRSS) at 12 months. Generalized estimating equation (GEE) models were used to account for within-participant inter-eye correlation. Univariable and multivariable GEE analyses were conducted to identify baseline factors independently associated with DR progression. Receiver operating characteristic analysis was performed for the individual markers and combined models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      During follow-up, 52 eyes (48.15%) showed DR progression and 56 eyes (51.85%) did not. In the final multivariable GEE model, higher temporal peripapillary VD (adjusted OR, 0.88; 95%CI, 0.81\u20130.95), higher deep VD within the 1\u20133-mm parafoveal annulus (adjusted OR, 0.86; 95% CI, 0.78\u20130.96;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.01), and higher lymphocyte count (adjusted OR, 0.31; 95% CI, 0.11\u20130.87;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.03) were associated with lower odds of progression. The AUCs were 0.72 for temporal peripapillary VD, 0.70 for deep parafoveal VD, and 0.70 for lymphocyte count. The OCTA model combining the two VD parameters achieved an AUC of 0.80 (95% CI, 0.72\u20130.88), whereas the OCTA-plus-lymphocyte model achieved an AUC of 0.84 (95% CI, 0.77\u20130.92). After internal validation by participant-level cluster bootstrap (500 resamples), the optimism-corrected AUC of the OCTA-plus-lymphocyte model was 0.83 (apparent AUC 0.84; optimism \u22640.012), and the 10-fold participant-level cross-validated AUC was 0.81 for the combined model vs. 0.78 for the OCTA-only model.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Lower temporal peripapillary VD, lower deep parafoveal VD, and lower peripheral blood lymphocyte count were associated with 12-month DR progression. Their combination demonstrated the highest apparent discrimination in this cohort. As this is a single-center exploratory cohort without external validation, these discriminative estimates should be regarded as apparent, and the model requires confirmation in larger, multicenter longitudinal studies before clinical application.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1951011","type":"journal-article","created":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:37:54Z","timestamp":1790915874000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Associations of multiregional OCTA metrics and systemic hematologic biomarkers With 12-month diabetic retinopathy progression"],"prefix":"10.3389","volume":"13","author":[{"given":"Lina","family":"Ge","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, The First Affiliated Hospital of Xinjiang Medical University","place":["Urumqi, Xinjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenghai","family":"Huang","sequence":"additional","affiliation":[{"name":"National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University","place":["Wenzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihe","family":"Zhou","sequence":"additional","affiliation":[{"name":"National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University","place":["Wenzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijin","family":"Huang","sequence":"additional","affiliation":[{"name":"National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University","place":["Wenzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoying","family":"Ye","sequence":"additional","affiliation":[{"name":"National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University","place":["Wenzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Huang","sequence":"additional","affiliation":[{"name":"National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University","place":["Wenzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyi","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, The First Affiliated Hospital of Xinjiang Medical University","place":["Urumqi, Xinjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,10,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1016\/j.ophtha.2021.04.027","article-title":"Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis","volume":"128","author":"Teo","year":"2021","journal-title":"Ophthalmology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"109119","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"B3","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/s001250051594","article-title":"UKPDS 50: risk factors for incidence and progression of retinopathy in type II diabetes over 6 years from diagnosis","volume":"44","author":"Stratton","year":"2001","journal-title":"Diabetologia"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/S0161-6420(03)00475-5","article-title":"Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales","volume":"110","author":"Wilkinson","year":"2003","journal-title":"Ophthalmology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1097\/IAE.0000000000000882","article-title":"Detection of microvascular changes in eyes of patients with diabetes but not clinical diabetic retinopathy using optical coherence tomography angiography","volume":"35","author":"de Carlo","year":"2015","journal-title":"Retina"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1016\/j.ophtha.2019.06.016","article-title":"OCT angiography metrics predict progression of diabetic retinopathy and development of diabetic macular edema: a prospective study","volume":"126","author":"Sun","year":"2019","journal-title":"Ophthalmology"},{"key":"B7","doi-asserted-by":"publisher","first-page":"3781","DOI":"10.1038\/s41433-023-02605-w","article-title":"Association of OCT and OCT angiography measures with the development and worsening of diabetic retinopathy in type 2 diabetes","volume":"37","author":"Srinivasan","year":"2023","journal-title":"Eye (Lond)"},{"key":"B8","doi-asserted-by":"publisher","first-page":"101111","DOI":"10.1016\/j.xops.2026.101111","article-title":"Using OCT angiography to predict diabetic retinopathy progression and vision decline in a multiethnic cohort","volume":"6","author":"Yang","year":"2026","journal-title":"Ophthalmol Sci"},{"key":"B9","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1080\/02713683.2023.2227363","article-title":"Longitudinal changes of parafoveal vessel density in diabetic patients without clinical retinopathy using optical coherence tomography angiography","volume":"48","author":"Wang","year":"2023","journal-title":"Curr Eye Res"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1007\/s00592-023-02086-z","article-title":"Early diagnosis of retinal neurovascular injury in diabetic patients without retinopathy by quantitative analysis of OCT and OCTA","volume":"60","author":"Li","year":"2023","journal-title":"Acta Diabetol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"100030","DOI":"10.1016\/j.xops.2021.100030","article-title":"Quantitative parameters from OCT angiography in patients with diabetic retinopathy and in those with only peripheral retinopathy compared with control participants","volume":"1","author":"Hogg","year":"2021","journal-title":"Ophthalmol Sci"},{"key":"B12","doi-asserted-by":"publisher","first-page":"5074","DOI":"10.1167\/iovs.18-24891","article-title":"Peripapillary microvascular and neural changes in diabetes mellitus: an OCT-angiography study","volume":"59","author":"Vujosevic","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B13","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.ajo.2022.07.008","article-title":"Parapapillary choroidal microvasculature predicts diabetic retinopathy progression and diabetic macular edema development: a three-year prospective study","volume":"245","author":"Guo","year":"2023","journal-title":"Am J Ophthalmol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1186\/s12916-023-02976-7","article-title":"Competing risks analysis for neutrophil to lymphocyte ratio as a predictor of diabetic retinopathy incidence in the Scottish population","volume":"21","author":"Rajendrakumar","year":"2023","journal-title":"BMC Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1396161","DOI":"10.3389\/fendo.2024.1396161","article-title":"Association between neutrophil-to-lymphocyte ratio and diabetic retinopathy in patients with type 2 diabetes: a cohort study","volume":"15","author":"Tang","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B16","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1055\/a-1931-4400","article-title":"Association between the variability of glycated hemoglobin and retinopathy in patients with type 2 diabetes mellitus: a meta-analysis","volume":"55","author":"Zhai","year":"2023","journal-title":"Horm Metab Res"},{"key":"B17","doi-asserted-by":"publisher","first-page":"110069","DOI":"10.1016\/j.diabres.2022.110069","article-title":"Mean HbA1c and HbA1c variability are associated with differing diabetes-related complications in patients with type 2 diabetes mellitus","volume":"192","author":"Wu","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1133290","DOI":"10.3389\/fendo.2023.1133290","article-title":"The concordance and discordance of diabetic kidney disease and retinopathy in patients with type 2 diabetes mellitus: a cross-sectional study of 26,809 patients from 5 primary hospitals in China","volume":"14","author":"Liu","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B19","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1093\/hmg\/ddab067","article-title":"Genome-wide polygenic risk score for retinopathy of type 2 diabetes","volume":"30","author":"Forrest","year":"2021","journal-title":"Hum Mol Genet"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.2337\/dc23-1691","article-title":"Hemoglobin A1c genetics and disparities in risk of diabetic retinopathy in individuals of genetically inferred African American\/African British and European ancestries","volume":"47","author":"Mandla","year":"2024","journal-title":"Diabetes Care"},{"key":"B21","doi-asserted-by":"publisher","first-page":"9643","DOI":"10.1038\/s41598-024-54306-3","article-title":"Optical coherence tomography angiography analysis methods: a systematic review and meta-analysis","volume":"14","author":"Courtie","year":"2024","journal-title":"Sci Rep"},{"key":"B22","doi-asserted-by":"publisher","first-page":"11206721221132629","DOI":"10.1177\/11206721221132629","article-title":"Temporal macular thinning and vessel density correlation in children and young adults with sickle cell disease","volume":"13","author":"Monteiro","year":"2022","journal-title":"Eur J Ophthalmol"},{"key":"B23","first-page":"218","article-title":"Adaptive local thresholding for detection of nuclei in diversity stained cytology images","author":"Phansalkar","year":"2011"},{"key":"B24","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1001\/jamaophthalmol.2024.2890","article-title":"Ultra-widefield and early treatment diabetic retinopathy study 7-field grading of diabetic retinopathy","volume":"142","author":"Aiello","year":"2024","journal-title":"JAMA Ophthalmol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.oret.2017.11.004","article-title":"Suspended scattering particles in motion: a novel feature of OCT angiography in exudative maculopathies","volume":"2","author":"Kashani","year":"2018","journal-title":"Ophthalmol Retina"},{"key":"B26","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1167\/iovs.65.6.11","article-title":"Intereye microvascular differences in patients with same-stage diabetic retinopathy revealed by OCTA","volume":"65","author":"Stino","year":"2024","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B27","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ajo.2022.07.001","article-title":"Peripapillary microvasculature predicts the incidence and development of diabetic retinopathy: an SS-OCTA study","volume":"243","author":"Yuan","year":"2022","journal-title":"Am J Ophthalmol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"5014035","DOI":"10.1155\/2020\/5014035","article-title":"Quantification of microvascular density of the optic nerve head in diabetic retinopathy using optical coherence tomographic angiography","volume":"2020","author":"Huang","year":"2020","journal-title":"J Ophthalmol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1136\/bjophthalmol-2020-317322","article-title":"Longitudinal analysis of microvascular perfusion and neurodegenerative changes in early type 2 diabetic retinal disease","volume":"106","author":"Aschauer","year":"2022","journal-title":"Br J Ophthalmol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"5188","DOI":"10.1167\/iovs.17-22593","article-title":"Wide-field OCT angiography investigation of the relationship between radial peripapillary capillary plexus density and nerve fiber layer thickness","volume":"58","author":"Jia","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B31","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1167\/iovs.63.6.4","article-title":"The ganglion cell-inner plexiform layer thickness\/vessel density of superficial vascular plexus ratio according to the progression of diabetic retinopathy","volume":"63","author":"Sung","year":"2022","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B32","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1167\/iovs.66.2.32","article-title":"Relationship of OCT-based diabetic retinal neurodegeneration to the development and progression of diabetic retinopathy: a cohort study","volume":"66","author":"Tang","year":"2025","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B33","doi-asserted-by":"publisher","first-page":"800004","DOI":"10.3389\/fnins.2021.800004","article-title":"Retinal neurodegeneration in different risk phenotypes of diabetic retinal disease","volume":"15","author":"Madeira","year":"2021","journal-title":"Front Neurosci"},{"key":"B34","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.oret.2022.06.018","article-title":"Deep capillary nonperfusion on OCT angiography predicts complications in eyes with referable nonproliferative diabetic retinopathy","volume":"7","author":"Ong","year":"2023","journal-title":"Ophthalmol Retina"},{"key":"B35","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1001\/jamaophthalmol.2023.1821","article-title":"Assessment of parafoveal diabetic macular ischemia on optical coherence tomography angiography images to predict diabetic retinal disease progression and visual acuity deterioration","volume":"141","author":"Yang","year":"2023","journal-title":"JAMA Ophthalmol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.ajo.2022.11.018","article-title":"Choriocapillaris flow deficit as a biomarker for diabetic retinopathy and diabetic macular edema: 3-year longitudinal cohort","volume":"248","author":"Chen","year":"2023","journal-title":"Am J Ophthalmol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.3390\/jcm10112296","article-title":"Optical coherence tomography angiography metrics monitor severity progression of diabetic retinopathy-3-year longitudinal study","volume":"10","author":"Marques","year":"2021","journal-title":"J Clin Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.oret.2024.02.017","article-title":"Clinical features related to OCT angiography artifacts in patients with diabetic macular edema","volume":"8","author":"Tamer Kaderli","year":"2024","journal-title":"Ophthalmol Retina"},{"key":"B39","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1186\/s12886-025-04075-y","article-title":"Exploring leukocyte differential count ratio profiles as inflammatory biomarkers in diabetic retinopathy: a systematic review and meta-analysis","volume":"25","author":"Harley","year":"2025","journal-title":"BMC Ophthalmol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"6499","DOI":"10.3390\/jcm11216499","article-title":"The role of adaptive immunity in diabetic retinopathy","volume":"11","author":"Xue","year":"2022","journal-title":"J Clin Med"},{"key":"B41","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1186\/s12886-025-04222-5","article-title":"Evaluating neutrophil-lymphocyte ratio, systemic immune-inflammation index, and systemic inflammation response index for diagnosing and predicting progression in diabetic retinopathy: a cross-sectional and longitudinal study","volume":"25","author":"Gong","year":"2025","journal-title":"BMC Ophthalmol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"8796","DOI":"10.3390\/ijms24108796","article-title":"Inflammation: the link between neural and vascular impairment in the diabetic retina and therapeutic implications","volume":"24","author":"Ramos","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B43","doi-asserted-by":"publisher","first-page":"3827","DOI":"10.2147\/DMSO.S437580","article-title":"Exploring the correlation between the systemic immune inflammation index (SII), systemic inflammatory response index (SIRI), and type 2 diabetic retinopathy","volume":"16","author":"Wang","year":"2023","journal-title":"Diabetes Metab Syndr Obes"},{"key":"B44","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1001\/jamaophthalmol.2021.2809","article-title":"Evaluation of intravitreal aflibercept for the treatment of severe nonproliferative diabetic retinopathy: results from the PANORAMA randomized clinical trial","volume":"139","author":"Brown","year":"2021","journal-title":"JAMA Ophthalmol"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1951011\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:37:59Z","timestamp":1790915879000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1951011\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,2]]},"references-count":44,"alternative-id":["10.3389\/fmed.2026.1951011"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1951011","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,2]]},"article-number":"1951011"}}